
Your generous year-end donation will be matched $1 for $1 DONATE
News


The Difficult Question of When to Stop Treatment
Yesterday, I stumbled across the Twitter chat #whentostop, hosted by the Oncology Nursing Society (ONS), addressing one of the most…

WCOE: Different Treatment Options Require Consideration of Patient Preferences, and What We Can Learn from Price Transparency in Veterinary Medicine
In “Breast Cancer Chemotherapy Varies Widely: Study Raises Questions About Early Treatment Choices,” Dr. Elaine Schattner,…

Addressing the Gaps in Treatment Planning and Coordination with the PACT Act (H.R. 2477)
Recently we were reminded of the importance of the Planning Actively for Cancer Treatment (PACT) Act, H.R. 2477 as we participated…

WCOE: Making Hard Choices and the Impact of Price Transparency
In “Living with Cancer: Difficult Choices,” another installment in her series in The New York Times, Susan Gubar writes about…

Exploring Access to Unapproved Therapies
In a series entitled, “When Unapproved Drugs Are the Only Hope,” Meg Tirrell of CNBC takes an in-depth look into the complicated…

WCOE: Improving Quality for Patients by Delivering and Paying for Care Differently
In two America Tonight segments entitled, “Is America treating cancer the wrong way?” Michael Okwu of Al Jazeera America delves…

Balancing Patient Protections and Innovation: NCCS Applauds FDA Action to Regulate Laboratory-Developed Tests
The National Coalition for Cancer Survivorship (NCCS) commends the Food and Drug Administration (FDA) for taking critical steps to…